Methodology Considerations in Planning and Analysis of Studies of Drug-Disease Associations Using a Medicaid Data Base

  • R. T. O’Neill
Conference paper
Part of the Health Systems Research book series (HEALTH)


For post-marketing surveillance of drugs, the U.S. Food and Drug Administration (FDA) has been exploring the use of a computerized data base containing records of paid claims for health services provided to patients covered by the Medicaid programs of the states of Minnesota and Michigan. The data base currently consists of longitudinal records of up to 2 years coverage on almost 1.6 million patients, all of whom have prescription drug codes (NDC) or diagnosis codes (ICD-9CM) representing services for their periods of health coverage. The patient record is identified by demographics of age, sex, state, and geographic area, and the codes are indexed chronologically by date of service and provider identification.


Assure Phenylephrine Ephedrine Pseudoephedrine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • R. T. O’Neill
    • 1
  1. 1.Division of BiometricsNational Center for Drugs and Biologics, FDARockvilleUSA

Personalised recommendations